Purchase Order HHSN271201700611P
Award Date 9/7/17
Potential Completion Date 11/1/17
Potential Value $105K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Canada
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm-fixed-price purchase order to Chemdiv, Inc. to provide 10,000 proprietary chemical compounds at 8 micromolar each. The total potential value of the award is $128,000.00. The award was not set aside for any specific business type. The contract has a completion date of September 4, 2017.</p>
- The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $250,000.00 firm-fixed-price purchase order to the Baruch S. Blumberg Institute, a non-profit organization and foundation, for a project related to the "NATURAL PRODUCTS EXTRACTS LIBRARY" program. The award did not use a set-aside. The place of performance is Doylestown, Pennsylvania, and the award date was August 14, 2017, with a completion date of September 14, 2017.
- This is a $99,715.40 firm fixed-price purchase order awarded to Cisbio US, Inc., a foreign-owned for-profit company, by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The contract is for the provision of assay kits, cell lines, and collagen reagents to support research activities. This award was not set aside and is the latest in a series of similar purchase orders awarded to Cisbio US, Inc. to provide biomarker...
- This federal contract award, with an ID of HHSN271201500432P, was issued by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services (HHS), to Cisbio US, Inc., a foreign-owned for-profit company. The $128,330.00 firm-fixed-price purchase order contract was set aside for a small business. It was awarded on July 21, 2015, with an ultimate completion date of August 21, 2015. Based on Cisbio US, Inc.'s past federal contract experience, the contract...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $24,825 purchase order to Sigma-Aldrich, Inc. for contract 1107546 under contract number 23-005532. Performance will take place in Baltimore, Maryland over the course of one year beginning in September 2023. The firm fixed price contract is for the procurement of products or services to support NIH/NIDA research efforts, though details of the work were not provided....
- <p>The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Firm Fixed Price Purchase Order contract to Aushon Biosystems, Inc., a for-profit organization, for $124,879.00. The contract has a completion date of September 29, 2018 and was awarded on September 22, 2017. The place of performance is Billerica, MA 01821, USA. This contract does not have a set-aside designation.</p>
- <p>This is a $18,963.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to NINDS PHARMAC LLC for medicinal chemistry consulting services. The contract has a Total Small Business set-aside designation. The contract was awarded on January 12, 2017 and has an ultimate completion date of January 12, 2022. The place of performance is Bethesda, Maryland.</p>
- This federal contract award is a delivery order under a larger contract vehicle, with Research Triangle Institute (RTI) International as the prime contractor. The contract is with the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The award, valued at $376,358.00, is for the synthesis and distribution of drugs of abuse and related compounds over a one-year period from June 16, 2024 to June 15, 2025, with a total period of...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $12,087 purchase order to Med Associates, Inc., doing business as Med Associates, for unspecified services or products. The contract has a one-year period of performance beginning July 7, 2023 through July 6, 2024 and utilizes a firm fixed price contracting structure. Place of performance will be Med Associates' Baltimore, Maryland location. No additional details were...
- The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a $16,000 purchase order to Cellx, Inc., a small business, on September 29, 2025, for pharmaceutics formulation, chemistry manufacturing and controls (CMC) consulting services supporting drug discovery and development programs. The contract, which runs through September 28, 2028, provides specialized subject matter expert consultation for small molecules and biologics development, with...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $104,870.00 firm fixed price purchase order contract to Life Chemicals Inc., a for-profit organization, for services to be performed in Canada. The contract was not set aside for any special designation. The award was made on September 7, 2017, with a completion date of November 1, 2017.
Generated 3/23/24, 1:59 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $104.9k | 9/7/17 |